Parenteral Drug Delivery Flashcards

1
Q

What does ‘parental’ mean?

A

Not via gut; routes of administration other than the oral route (usually injected formulations).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the major routes of parenteral drug administration?

A
  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Intradermal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the minor routes of parenteral drug administration?

A
  • Intrathecal
  • Intra-arterial
  • Intra-articular (joints)
  • Intracardiac
  • Intraosseous (into bone marrow)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the specialised formulation needs of parenteral administration?

A
  • Sterility (bypass infection barriers)
  • Isotonic (equal osmolar concentration as inside cell)
  • pH 7.4 (physiological pH)
  • Small volumes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where is the drug injected with intradermal injection and what volume is tolerated?

A
  • Drug injected into superficial layer of skin

- 0.1 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is the drug injected with subcutaneous injection and what volume is tolerated?

A
  • Drug injected into loose connective tissue just below skin
  • 1.3 mL
  • Between intradermal and intravenous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where is the drug injected for intravenous injection and what volume is tolerated?

A
  • Durg injected into the vein
  • > 5 mL
  • Between subcutaneous and intramuscular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where is the drug injected for intramuscular and what volume is tolerated?

A
  • Drug injected into muscle mass
  • 2 mL
  • Deepest injection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the advantages of parenteral delivery?

A
  • IV drugs enters plasma immediately; rapidly disperses to tissues
  • Local/targeted effect achievable e.g. local anaesthetics, cytotoxics
  • 100% availability; drug does not have to cross absorption barriers in the gut, can administer drugs that are unabsorbed/degraded
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the problems/precautions with parenteral delivery?

A
  • Air embolism (blockage in blood supply); injection of air bubbles
  • Bleeding (e.g. in haemophilia; disorder where blood doesn’t clot normally)
  • Cost (training & specialised formulation)
  • Fever (from pyrogens; fever inducing substance produced from bacteria etc.)
  • Infiltration/extravasation (local tissue damage, needle in wrong place etc; accidental leaking of drug/fluid into extracellular space)
  • Overdosage (serious due to rapid onset)
  • Particulates (pulmonary embolism; arteries in lungs blocked by clotting)
  • Sepsis (must have sterile practice)
  • Thrombosis (blood clot)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the advantages of IV administration?

A
  • Rapidity; almost immediate effect (e.g. liquids injected into arm appear in leg within 20 - 30 seconds)
  • More predictable response than other routes; incomplete/poor absorption not an issue (blood levels more predictable)
  • Preferred for orally inactive drug (e.g. peptides)
  • Suitable for unconscious, uncooperative or nauseous patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the disadvantages of IV administration?

A
  • Requires extensive training; correct amount of drug into correct place with correct technique
  • Sterility must be maintained; sterile procedures during formulation, aseptic procedures during administration
  • Dosage error leads to serious injury or death
  • Complications e.g. extravasation, thrombosis, air embolism, phlebitis (inflammation of vein), haemolysis (rupture/destruction of RBCs)
  • Availability of sites (loss of sites in long-term treatment)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the trip the drug makes around the body upon IV administration (biopharmaceutics)

A
  • Drug injected to vein; passed to heart
  • Passes through pulmonary circulation
  • Heart pumps it around tissues
  • Blood flow in tissues is slow, so absorption is efficient (approx 1 mm/s)
  • Drug returns to heart through liver; metabolism begins
  • Round trip takes 10 - 30 seconds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens to the drug concentration in blood plasma with an IV bolus (short blast) injection over time?

A
  • Rapid increase in drug concentration in blood plasma (quick peak)
  • Distribution (Vd) of drug; concentration soon falls via reversible transfer of drug from blood plasma to body tissues
  • Drug concentration remaining in blood plasma affected by administered dose & quantity of drug transferred into body tissues
  • Drug concentration then decreases more slowly due to irreversible excretion & metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens to the drug concentration in blood plasma with a continuous IV infusion over time?

A
  • IV infusion administers large amount of fluid at slow rate; ensuring drug enters circulation at constant rate
  • Drug concentration in blood plasma rises soon after start of infusion and achieves steady state when rate of drug addition = rate of drug loss
  • Stopping infusion; elimination of drug from body by metabolism & excretion follows first-order kinetics.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are small volumes of drug administered IV?

A
  • Can be injected directly (slowly if concentrated)

- Often mixed with other LVPs (large volume parenterals) such as glucose/buffers, can cause compatibility problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the two ways of administering a continuous infusion and their differences?

A
  • Drip feed via gravity (where rate does not matter; poor control)
  • Or via metering pump where drug is pumped at known rate via catheter into vein (e.g. analgesia for chemotherapy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How are large volumes administered IV?

A

Via a central venous catheter (into a large vein e.g. veins in the neck (internal jugular vein), chest (subclavian vein or axillary vein), groin (femoral vein), or through veins in the arms (PICC line)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is classed as a small volume parenteral and what are their formulation requirements?

A

-

20
Q

Why do we allow for a small volume parenteral formulation to be of pH 3 - 9?

A

To accommodate formulation solubility; may not be soluble near physiological pH

21
Q

What is classed as a large volume parenteral and what are their formulation requirements?

A
  • > 100mL
  • pH much more tightly controlled (6 to 8) due to high volume delivered
  • Usually made isotonic with glucose or NaCl (harmless)
  • Preservatives not permitted (don’t want large volumes of potentially nasty chemicals)
22
Q

What are the consequences of a small volume parenteral lying outside the pH range 3 - 9?

A

pH > 9 = tissue necrosis

pH

23
Q

What are the consequences of a large volume hypertonic solution? (should be isotonic)

A
  • Higher osmotic pressure than blood plasma

- Red blood cells lose fluids and shrink

24
Q

What are the consequences of a large volume hypotonic solution? (should be isotonic)

A
  • Lower osmotic pressure than blood plasma

- Fluid passes into RBCs by osmosis, blood cells swell and burst

25
Q

What are large volume parenterals used for?

A
  • Electrolyte balance
  • Parenteral nutrition
  • Plasma replacement
  • Acid-base balance
  • Contrasts agents
26
Q

Why is intramuscular drug delivery dece?

A
  • Muscle is well supplied with blood so absorption can be rapid
  • Big target; centimetres of muscle
  • Provides ‘depot’ effect; injection into tissue, takes a little while for dispersion and thus absorption (effect used deliberately too)
27
Q

What formulations can the ‘depot’ effect be most achieved in IM?

A
  • Suspensions
  • Depot implants
  • Formulations designed to precipitate upon injection and then slowly redissolve in blood
28
Q

How do IM formulations differ from IV and what advantages does this offer?

A
  • Slower onset but greater duration
  • Injections need not be water-miscible/soluble; suspensions in oil can be used, thus can deliver drugs not soluble in water (suspend in fine oil particles)
29
Q

What is the limit in volume for Im injections in different areas and why?

A

Small volume route:
2 mL; deltoid of arm
5 mL; gluteal (bum) region
Tissues disrupted; pain.

30
Q

What is of note when choosing an IM injection site?

A
  • Avoiding major nerves/blood vessel

- E.g. if particles etc. suspended meant for IM go IV then potentially v. harmful

31
Q

What is the issue with IM injection in infants not found in adults?

A
  • For adults; upper outer quadrant of gluteus maximus commonly used
  • But for infants, gluteal area is small & composed mostly of fat (muscle poorly developed/poor perfusion, too close to sciatic nerve esp. if child resisting)
  • Inject to deltoid muscles of upper arm (well away from radial nerve) or mid lateral muscles of thigh
32
Q

What are the advantages of IM delivery?

A
  • Rapid absorption (faster than oral, slower than IV)
  • Can formulate sustained depot (days/months)
  • Implanted devices may be removable (modern ones biodegradable; polymer system)
33
Q

What are the disadvantages in IM delivery?

A
  • Local muscle damage
  • Can’t use in cardiac failure (no muscle perfusion)
  • Must avoid blood vessels
34
Q

What are the pharmacokinetics of IM drug delivery (path of drug from injection to body)?

A
  • Injection of drug into muscle
  • Release of drug fro dose form into intracellular fluid (ICF)
  • Absorption from ICF into blood (capillaries) and lymphatics
  • Transport from local blood volume (capilaries) to general circulation
  • Metabolism
35
Q

What factors affect IM absorption rate?

A
  • Extremely hydrophobic drugs do not dissolve in ICF (not comfortable in aqueous fluids; but may be advantage to give slow release; precipitate effect)
  • Strongly ionised or extremely water soluble drugs will dissolve in ICF but will not be able to cross capillary membrane (to get into circulation)
  • Strongly protein-bound drugs are slowly absorbed
  • Muscle movement & blood flow (get blood flowing so drug dispersed more quickly = less painful) affect absorption
  • Some drugs in solution absorbed slowly if composition of formulation changes after injection
36
Q

How is phenytoin formulated for IM injection?

A
  • Formulated at pH 12 due to its low solubility
  • On injection ICF quickly reduces pH to normal levels and drug precipitates
  • Takes several days for dose to be fully absorbed; advantage so drug not required to be given regularly
37
Q

How do intradermal and subcutaneous injection differ?

A
  • SC tissues have significant volume of interstitial fluid where drug can diffuse (loose tissues)
  • Epidermal tissue has little available fluid, poorly perfused by blood
  • Thus epidermal injections persist at site for long periods & available volume for injection is small (0.1 mL) e.g. tuberculin & allergy testing
38
Q

What does SC delivery entail?

Examples.

A
  • Injection into fatty & connective tissue
  • Aqueous solutions or suspensions of 1.3 to 2 mL
  • Absorption of insulin in thigh faster than abdominal site
  • Cannot give formulations which cause local irritation
  • Used for insulin, vaccines, some vitamins
39
Q

How does the rate of absorption with SC differ with IM?

A
  • Less well perfused than IM so slower absorption (often adipose tissue not muscle)
  • Lipophilic/hydrophobic drugs can diffuse/partition into fat tissue, resulting in delayed delivery
40
Q

Where is insulin inactivated?

A

In the liver and kidney in the same way physiological insulin is; 10% excreted in urine

41
Q

How do long acting insulin formulations achieve their effect?

A

Produced by precipitating insulin with protamine or Zn (salts of insulin) to form fine amorphous solid/insoluble crystals, forming dimers/hexamers which are injected as suspensions from which insulin is slowly absorbed

42
Q

Do rapid/ultra short actin insulin preparations contain Zn?

A

Traces of Zn, clear solution, neutral pH.

43
Q

What is the composition of short-acting insulin?

A

Regular insulin, soluble crystalline Zn insulin

44
Q

What is the composition of intermediate-acting insulin?

A
  • Suspension of Zinc insulin crystalline, 2 μm particle size.
  • Onset delayed by combination of insulin and protamine e.g. NPH (Neutral Protamine Hagedorn)
45
Q

What is the composition of long-acting insulin?

A
  • Suspension mixture of 30% Semilente (amorphous precipitate of insulin with Zn ions for rapid onset) and 70% Ultralente (poorly soluble crystal of Zn insulin for delayed onset and prolonged duration) giving rapid absorption with sustained long action, 10 - 40 μm particle size.